Advertisement
Advertisement
U.S. markets open in 4 hours 59 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Cannabis Suisse Corp. (CSUI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0500-0.0036 (-6.72%)
At close: 03:57PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0536
Open0.0487
BidN/A x N/A
AskN/A x N/A
Day's Range0.0421 - 0.0500
52 Week Range0.0102 - 0.0820
Volume86,353
Avg. Volume242,688
Market Cap1.825M
Beta (5Y Monthly)-0.61
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CSUI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANNABIS SUISSE CORP
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
Advertisement
Advertisement